Contents
Issue 122 • September 2022
In association with
In association with
Comment
Tapping into pharma’s growing opportunities in digital health
Covid-19 Omicron boosters will reinvigorate injectables manufacturing
Implementation of electronic health records will improve the quality of care
Despite benefits, long-acting injectables remain underutilised for schizophrenia
Coherus’ Cimerli bags approval for DME with year-long interchangeability exclusivity
UK health data collaboration paves the way to study Long Covid symptoms
In Depth
NICE makeover: a new look for UK HTAs
No drugs for prions: quelling therapeutic scarcity
Getting smart with digital pills
Can generics producers tackle complex and specialty drugs?
Decentralised paediatric clinical trials trending up but study execution critical
CMO Moves: Regulatory catalysts for drug manufacturing- August
Comment
Tapping into pharma’s growing opportunities in digital health